Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives
Dr. Matthew Johnson’s research found that 59% of nicotine-addicted patients remained abstinent from smoking for 12 months after receiving a single macrodose of psilocybin. Only 28% of patients on a nicotine patch remained abstinent for the same time period.
His other research shows that multiple psilocybin doses can have an 80% success rate!
